Levodopa (Carbidopa/Levodopa)
Treatment for Parkinson's disease
Effectiveness
92%
Safety Score
65%
Clinical Trials
171
Participants
300K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
0
Levodopa (Carbidopa/Levodopa) Outcomes
for Parkinson's disease
Efficacy Outcomes
Overall Effectiveness
+92%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
16 completed trials for Levodopa (Carbidopa/Levodopa) in Parkinson's disease
Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off
NCT00391898COMPLETEDPHASE4
95 participants
INTERVENTIONAL
A Coruña, Spain +25 more
Started: Oct 1, 2006
Measuring Parkinson's Disease Progression
NCT03205956COMPLETEDPHASE1
31 participants
INTERVENTIONAL
St Louis, United States
Started: Oct 19, 2017
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
NCT00099268COMPLETEDPHASE3
747 participants
INTERVENTIONAL
Birmingham, United States +72 more
Started: Sep 1, 2004
Stalevo in Early Wearing-Off Patients
NCT00125567COMPLETEDPHASE4
223 participants
INTERVENTIONAL
Aalborg, Denmark +18 more
Started: Aug 1, 2005
Pharmacokinetic Study in Healthy Volunteers
NCT02554734COMPLETEDPHASE1
15 participants
INTERVENTIONAL
Turku, Finland
Started: Aug 1, 2015
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
NCT00558337COMPLETEDPHASE2
78 participants
INTERVENTIONAL
Buenos Aires, Argentina +8 more
Started: Nov 1, 2007
Levodopa Concentration Profile With Stalevo 75/125 mg
NCT01070628COMPLETEDPHASE1
20 participants
INTERVENTIONAL
Espoo, Finland
Started: Dec 1, 2009
A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
NCT02486432COMPLETEDPHASE1
6 participants
INTERVENTIONAL
Started: Apr 1, 2015
PharmacoMRI of Parkinson Disease
NCT01528592COMPLETEDNA
18 participants
INTERVENTIONAL
Chicago, United States
Started: Jun 1, 2011
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
NCT02764125COMPLETEDPHASE2
84 participants
INTERVENTIONAL
Turku, Finland +3 more
Started: Apr 8, 2016
A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics
NCT01026428COMPLETEDPHASE1, PHASE2
24 participants
INTERVENTIONAL
Casino, Italy +1 more
Started: Sep 1, 2009
Pharmacokinetic Study in Healthy Males
NCT02312232COMPLETEDPHASE1
20 participants
INTERVENTIONAL
Turku, Finland
Started: Nov 1, 2014
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
NCT01130493COMPLETEDPHASE3
110 participants
INTERVENTIONAL
Fresno, United States +23 more
Started: May 1, 2010
A Phase 2a Study Followed to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients Receiving ND0612
NCT01883505COMPLETEDPHASE2
30 participants
INTERVENTIONAL
Jerusalem, Israel +2 more
Started: Jan 6, 2014
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
NCT01484990COMPLETEDPHASE1
19 participants
INTERVENTIONAL
Started: Apr 1, 2010
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026COMPLETEDPHASE4
184 participants
INTERVENTIONAL
Adelaide, Australia +17 more
Started: Jul 1, 2005
Showing 20 of 173 total trials